Chelation in Metal Intoxication

By S. Flora, V. Pachauri. International Journal of Environmental Research and Public Health, 2010

851 citations recorded by the source corpus.

Chelation therapy is the preferred medical treatment for reducing the toxic effects of metals. Chelating agents are capable of binding to toxic metal ions to form complex structures which are easily excreted from the body removing them from intracellular or extracellular spaces. 2,3-Dimercaprol has long been the mainstay of chelation therapy for lead or arsenic poisoning, however its serious side effects have led researchers to develop less toxic analogues. Hydrophilic chelators like meso-2,3-dimercaptosuccinic acid effectively promote renal metal excretion, but their ability to access intracellular metals is weak. Newer strategies to address these drawbacks like combination therapy (use of structurally different chelating agents) or co-administration of antioxidants have been reported recently. In this review we provide an update of the existing chelating agents and the various strategies available for the treatment of heavy metals and metalloid intoxications.

Subfields: Health, Toxicology and Mutagenesis, Nutrition and Dietetics, Plant Science

View Paper: https://www.semanticscholar.org/paper/9915fd1cc4b736b85eabd63bc11ff508b2df49d7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. G. Genchi
  2. M. Sinicropi
  3. G. Lauria
  4. A. Carocci
  5. Alessia Catalano
  6. Mehravar Rafati Rahimzadeh
  7. A. Moghadamnia
  8. Mehrdad Rafati Rahimzadeh

Citations in the corpus